Chemical Structure : PF-04457845
CAS No.: 1020315-31-4
Catalog No.: PC-20049Not For Human Use, Lab Use Only.
PF-04457845 (Redafamdastat) is a highly potent, selective and covalent fatty acid amide hydrolase (FAAH) inhibitor with IC50 of 7.2 nM (human FAAH).
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $88 | In stock | |
25 mg | $148 | In stock | |
50 mg | $248 | In stock | |
100 mg | $398 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PF-04457845 (Redafamdastat) is a highly potent, selective and covalent fatty acid amide hydrolase (FAAH) inhibitor with IC50 of 7.2 nM (human FAAH).
PF-04457845 displays no activity against other FP-reactive serine hydrolases at 100 uM, as well as a broad panel of 68 targets including receptors, enzymes, ion channels, and transporters.
PF-04457845 is orally bioavailable, and PF-04457845 (10 mg/kg, p.o.) displays antihyperalgesic activity with long duration of action in the CFA model of inflammatory pain in rats.
PF-04457845 does not elicit effect in motility, catalepsy, and body temperature.
M.Wt | 455.44 | |
Formula | C23H20F3N5O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-pyridazin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide |
1. Sébastien Dilly, et al. Antioxidants (Basel). 2023 Feb 10;12(2):440.
2. Li Yet al. Proc. Natl. Acad. Sci. USA. 2012;109:12526–12531.
3. Ahn K, et al. J Pharmacol Exp Ther. 2011 Jul;338(1):114-24.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright